FDA approved expanded use of Wegovy for cardiovascular disease caused by being overweight, as concerns continue to grow about reports of stomach paralysis injuries some users are experiencing.
The researchers indicate the findings highlight the importance of screening and preventative care for gestational diabetes and pregnancy-related hypertension.
The cost of Ozempic, Wegovy and other similar diet drugs often exceeded most people's "willingness-to-pay" price point for the weight loss benefits they provided, researchers noted.
Lawsuit comes amid increasing concerns over the widespread use of Wegovy and Ozempic, which have been linked to reports of severe and debilitating stomach paralysis.
Researchers found that the higher the level of prenatal exposure to PFAS, the higher the risk of child obesity.
Higher levels of PFAS exposure through drinking water led to study participants gaining lost weight back, regardless of the diet they were on, the study warns
Researchers warn that exposure to PFAS may impact children's metabolism in a way that increases inflammation and oxidative stress.
Increases of diabetes, hypertension and other heart risks disproportionately increased among people of color, researchers warn.
A new study suggests millions of cancer cases could be prevented by lifestyle changes and avoiding smoking.
Exposure to PFAS chemicals has been tied to 13 major health problems, costing the U.S. healthcare system between $5.5 billion and $63 billion over the current population' lifetime.
